Recently chief architect of
global patent enforcement strategy in support of a $ 200MM + annual licensing program, including filing - to - trial litigation experience in Japan, Germany, UK and US.
Not exact matches
Main areas of work Mergers and acquisitions, securities, domestic and international tax, employee benefits, financial institutions,
global sourcing and technology, government relations, real estate finance and capital markets, real estate investment and development, chemistry and life sciences,
patent litigation, trademark and copyright, electronics and software, medical and mechanical devices, bankruptcy and financial restructuring, complex commercial litigation, construction and infrastructure projects, environmental and sustainable development, government
enforcement and investigations, insurance recovery, labor and employment, native american affairs.
Mark Ridgway Qualified: 2004 Made partner: 2015 Key cases: Representing Pfizer group company Warner - Lambert in its pan-European
enforcement efforts in relation to its second medical use
patent for its blockbuster drug Lyrica; acted for Novartis Pharmaceuticals on a multijurisdictional biotechnological
patent dispute relating to the blockbuster drug Lucentis; advising Blackberry on several high profile,
global patent disputes.
In addition to
patent litigation and licensing, Irene has extensive experience in trademark prosecution, litigation, and licensing with an emphasis on
global brand expansion and management through strategic trademark and copyright protection and
enforcement programs.
Leading the litigation and opposition areas has made him responsible of defining and coordinating the
global IP
enforcement, defence strategies and actions guiding the
global patent prosecution policy of the company.